Sci Pharmtech (TPE:4119) LT-Debt-to-Total-Asset : 0.14 (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Sci Pharmtech LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Sci Pharmtech's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.14.

Sci Pharmtech's long-term debt to total assets ratio increased from Mar. 2023 (0.10) to Mar. 2024 (0.14). It may suggest that Sci Pharmtech is progressively becoming more dependent on debt to grow their business.

Sci Pharmtech LT-Debt-to-Total-Asset Historical Data

The historical data trend for Sci Pharmtech's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sci Pharmtech LT-Debt-to-Total-Asset Chart

Sci Pharmtech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.09

0.13

Sci Pharmtech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.10	0.11	0.13	0.13	0.14

Sci Pharmtech LT-Debt-to-Total-Asset Calculation

Sci Pharmtech's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	845.528	/	6690.741
	=	0.13

Sci Pharmtech's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	915.12	/	6698.858
	=	0.14

Sci Pharmtech (TPE:4119) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Sci Pharmtech LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Sci Pharmtech's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Sci Pharmtech (TPE:4119) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sci Pharmtech Inc (TPE:4119) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.61, Lane 309, Haihu North Road, Luzhu District, Taoyuan, TWN, 33856

Website

http://www.sci-pharmtech.com.tw

Sci Pharmtech Inc is engaged in research and development, manufacture and sale of active pharmaceutical ingredients, intermediates, specialty chemicals. Geographically, the primary markets of company are Italy, Germany, Japan, Taiwan, United states, China, Switzerland, Spain and others.

Sci Pharmtech (TPE:4119) Headlines

No Headlines